行情

SYNH

SYNH

SYNEOS HEALTH
NASDAQ

实时行情|Nasdaq Last Sale

50.97
-0.37
-0.72%
已收盘, 16:00 11/18 EST
开盘
51.36
昨收
51.34
最高
51.40
最低
50.52
成交量
30.92万
成交额
--
52周最高
56.34
52周最低
36.27
市值
52.90亿
市盈率(TTM)
64.66
分时
5日
1月
3月
1年
5年

分析师评级

13位分析师的综合评级

买入

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

EPS

SYNH 新闻

  • 沪指低开高走 鲍威尔同特朗普及美财长会晤
  • 新浪财经.28分钟前
  • 日本众院通过日美贸易协定 执政党力争12月获批
  • 中国新闻网.1小时前
  • 汇丰:英镑前路难以预测 飙升与崩跌皆有可能
  • 新浪财经综合.1小时前
  • 英国大选进入白热化阶段 约翰逊“四问”科尔宾
  • 中国新闻网.2小时前

更多

所属板块

生物技术和医学研究
+0.31%
制药与医学研究
+0.13%

热门股票

名称
价格
涨跌幅

SYNH 简况

Syneos Health, Inc., formerly INC Research Holdings, Inc., is a global contract research organization (CRO). The Company focuses on Phase I to Phase IV clinical development services for the biopharmaceutical and medical device industries. The Company operates through two segments: Clinical Development Services and Phase I Services. The Company's Clinical Development Services segment offers a range of clinical development services, including full-service global studies, as well as ancillary services, such as clinical monitoring, investigator recruitment, patient recruitment, data management, study reports to assist customers with their drug development process, quality assurance audits and specialized consulting services. The Phase I Services segment focuses on clinical development services for Phase I trials, which include scientific exploratory medicine, first-in-human studies through proof-of-concept stages and support for Phase I studies in established compounds.
展开

Webull提供Syneos Health Inc的股票价格,实时市场报价,专业分析师评级,深度图表和免费的股票新闻,以帮助您做出投资决策。